These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9207450

  • 1. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.
    Ichihara M, Hara T, Kim H, Murate T, Miyajima A.
    Blood; 1997 Jul 01; 90(1):165-73. PubMed ID: 9207450
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Leukemia inhibitory factor (LIF) and oncastsin M (OSM) high affinity binding require additional receptor subunits besides GP130 and GP190.
    Heymann D, Godard A, Raher S, Bentouimou N, Blanchard F, Cherel M, Hallet MM, Jacques Y.
    Cytokine; 1996 Mar 01; 8(3):197-205. PubMed ID: 8833034
    [Abstract] [Full Text] [Related]

  • 4. Cloning and biological activity of murine oncostatin M.
    Hara T, Ichihara M, Yoshimura A, Miyajima A.
    Leukemia; 1997 Apr 01; 11 Suppl 3():449-50. PubMed ID: 9209421
    [Abstract] [Full Text] [Related]

  • 5. Cloning and characterization of a specific receptor for mouse oncostatin M.
    Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA.
    Mol Cell Biol; 1998 Jun 01; 18(6):3357-67. PubMed ID: 9584176
    [Abstract] [Full Text] [Related]

  • 6. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC, Johnson RW, Hu Y, Brennan HJ, Poulton IJ, Zhang JG, Jenkins BJ, Smyth GK, Nicola NA, Sims NA.
    J Biol Chem; 2016 Oct 07; 291(41):21703-21716. PubMed ID: 27539849
    [Abstract] [Full Text] [Related]

  • 7. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K, Taga T, Kishimoto T, Nakamura S.
    J Clin Invest; 1995 Sep 07; 96(3):1319-27. PubMed ID: 7657807
    [Abstract] [Full Text] [Related]

  • 8. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
    Plun-Favreau H, Perret D, Diveu C, Froger J, Chevalier S, Lelièvre E, Gascan H, Chabbert M.
    J Biol Chem; 2003 Jul 18; 278(29):27169-79. PubMed ID: 12707269
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
    Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B.
    Science; 1992 Mar 13; 255(5050):1434-7. PubMed ID: 1542794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H.
    J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.
    J Biol Chem; 2000 Feb 25; 275(8):5648-56. PubMed ID: 10681548
    [Abstract] [Full Text] [Related]

  • 16. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W, Bell M, Carroll G.
    Cytokine; 2000 Feb 25; 12(2):151-5. PubMed ID: 10671300
    [Abstract] [Full Text] [Related]

  • 17. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D.
    J Biol Chem; 1996 Dec 20; 271(51):32635-43. PubMed ID: 8999038
    [Abstract] [Full Text] [Related]

  • 18. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F.
    J Immunol; 2000 Sep 01; 165(5):2535-43. PubMed ID: 10946280
    [Abstract] [Full Text] [Related]

  • 19. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK, De Imus C, Gearing D, Baumann H, Mosley B.
    J Biol Chem; 1997 Jun 13; 272(24):15135-44. PubMed ID: 9182534
    [Abstract] [Full Text] [Related]

  • 20. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC.
    J Clin Invest; 1996 Jan 15; 97(2):431-7. PubMed ID: 8567964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.